Diego A. Pereira‐Martins

Author

Also Known As

D. A Pereira-Martins, D. A. Pereira-Martins, D.A. Pereira-Martins, D.A. Pereira‐Martins, Diego A Pereira-Martins, Diego A Pereira‐Martins, Diego A. P. Martins, Diego A. Pereira Martins, Diego A. Pereira-Martins, Diego A. Pereira‐Martins

153

Publications

831

Citations

H-Index

Concepts

All Affiliations

Universidade de São Paulo Universidade Federal de Pernambuco University Medical Center Groningen University of Groningen Universidade Estadual de Campinas (UNICAMP)

About

Diego A. Pereira‐Martins is an author at Universidade de São Paulo specializing in medicine, hematology, and oxidative stress.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	163
2	Natural Sciences	2	2	55
3	Biochemistry	2	2	55
4	Health Sciences	1	1	13
5	Allergy	1	1	48

Diego A. Pereira‐Martins

Publications

565

Citations

H-Index

Page 1

	Year	Citations
The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia Ayşegül Erdem, Silvia Marín, Diego A. Pereira‐Martins, Nature Communications	2022	55
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism Isabel Weinhäuser, Diego A. Pereira‐Martins, Luciana Yamamoto Almeida, Science Advances	2023	49
High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia Igor F. Domingos, Diego A. Pereira‐Martins, Marcondes J. Sobreira, Annals of Hematology InflammationCytokineAllergyPoor Clinical OutcomeImmune Regulation	2020	48
Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability Ayşegül Erdem, Silvia Marín, Diego A. Pereira‐Martins, Nature Communications	2022	48
Dietary methionine starvation impairs acute myeloid leukemia progression Alan Cunningham, Ayşegül Erdem, Islam Alshamleh, Blood	2022	44
PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia Keli Lima, Juan Luiz Coelho‐Silva, Gabriela Sarti Kinker, Cancer Genetics Hematological MalignancyOncologyMedicineAcute Myeloid LeukemiaCytogenetic Risk	2019	34
Acquired<scp><i>TERT</i></scp>promoter mutations stimulate<scp><i>TERT</i></scp>transcription in mantle cell lymphoma Julieta Panero, Raquel M. Alves‐Paiva, Alejandro Roisman, American Journal of Hematology	2016	30
Global analysis of erythroid cells redox status reveals the involvement of Prdx1 and Prdx2 in the severity of beta thalassemia Karen Simone Romanello, Karina Kirschner Lopes Teixeira, Sheila T. Nagamatsu, PLoS ONE Iron MetabolismImmunologyBlood CellMolecular BiologyPrdxs 1	2018	30
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia Antonio R. Lucena‐Araujo, Juan Luiz Coelho‐Silva, Diego A. Pereira‐Martins, Blood	2019	25
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy Keli Lima, Diego A. Pereira‐Martins, Lívia Bassani Lins de Miranda, Blood Cancer Journal	2022	25

Page 1